New drugs offer options.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000284:Administration, Oral; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D000077592:Maraviroc; D009930:Organic Chemicals / Q000008:administration & dosage / Q000627:therapeutic use*; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D003510:Cyclohexanes; D009930:Organic Chemicals; D011760:Pyrrolidinones; D014230:Triazoles; D000068898:Raltegravir Potassium; D000077592:Maraviroc